Category: Pharma
Oncology Breakthroughs: How Cancer Research Is Advancing in 2025
USA News Group Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – Now that World Cancer Day (Feb. 4) has come and gone, the world and the market are looking towards what’s being...
Read MoreInvestors Eye Biotech Sector as Cancer Therapy Market Surges
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – Amid the excitement surrounding Project Stargate—the $500 billion investment aimed at revolutionizing...
Read MoreCutting-Edge Cancer Therapies Lead the Way into a Transformative Year
USA News Group – News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – As 2025 begins, the American Association for Cancer Research (AACR) recently published forecasts...
Read MoreHow Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options
USA News Group Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – Recent advancements in cancer treatment continue to underscore the transformative potential of innovative...
Read MoreCancer Care Disruptions Highlight Growing Demand for Innovative Oncology Treatments
USA News Group Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – The American Cancer Society recently released its Advances in Oncology – 2024 Research Highlights report that...
Read MoreHealthcare Executives Embrace Generative AI to Boost Patient Outcomes
USA News Group Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – The healthcare industry is in the midst of a significant shift, driven by advancements in artificial intelligence...
Read MoreBiotech Advances Drive Cancer Research as Global Rates Continue Upward Trend
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – Despite death rates for some cancers being on the decline, there is a global surge in cancer cases among...
Read MoreBiotech Companies’ Q3 Updates: Promising Cancer Treatments on the Horizon
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER / USA News Group / News Commentary – As many biotech companies within the oncology space begin to roll out their end-of-quarter results, the...
Read MoreBreast Cancer Awareness Month Sees Biotech Advancements and Worrying Trends for Young Women
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – With every October, breast cancer awareness surges thanks to very effective campaigns and new developments...
Read MoreFDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Oct. 4, 2024 /PRNewswire/ — USA News Group News Commentary – While some forms of cancer are seeing death rates fall, the world is...
Read MoreBIOVAXYS ANNOUNCES UPSIZING OF PRIVATE PLACEMENT
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, Sept. 20, 2024 — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (“BioVaxys” or the...
Read MoreOncolytics Biotech® Reports Favorable Results for BRACELET-1 Breast Cancer Study Reinforcing Path to Funding of a Registration-Enabling Study
Overall survival (OS) results from BRACELET-1 corroborate results of previous randomized IND-213 breast cancer study Together, these two studies support the compelling potential of pelareorep-based combination therapy to benefit...
Read More